Farxiga (dapaglifozin) has been approved by the U.S. Food and Drug Administration to treat adults with type 2 diabetes, the agency said Wednesday in a news release. The drug, to be used for blood sugar control along with proper diet and ...
Tags: Farxiga, Type 2 Diabetes, Medicine News
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF ...
Tags: FDA, Combination Drug
The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine
The U.S. Food and Drug Administration warns consumers some over-the-counter laxatives may be dangerous if dosing instructions or warnings are not followed. There have been dozens of reports of serious side effects, including 13 deaths, ...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Officials Confirm First North American Death From H5N1 Bird Flu The first death in North America from H5N1 bird flu has been ...
Tags: Health Highlights, Health
A new combination of drugs might prolong life in certain older leukemia patients, a new study suggests. The research, led by German scientists, included nearly 800 older people (average age 73) who had been diagnosed with chronic ...
Tags: Drug, Drug Combo, Leukemia
CTCA to be recognized at A.S.P.E.N Conference in January 2014 Cancer Treatment Centers of America® (CTCA) has been recognized by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) with the organization's ...
If you are constipated and need to use a laxative, the U.S. Food and Drug Administration wants you to know that some products can be dangerous if you don't follow the dosing instructions or you have certain medical conditions. The agency ...
Three hundred children are being recruited for a clinical trial to establish whether or not specialist silk clothing really does help in the treatment of eczema. The £1m CLOTHES trial — Clothing for the relief of Eczema ...
Tags: clinical trial, silk clothing, eczema, Kim Thomas
The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some serious risks. The agency asked the maker, Genzyme, to test the drug in more clinical trials. The drug was ...
Tags: FDA, Lemtrada, Genzyme, relapsing-remitting MS, rejection
In experiments with rodents, scientists have discovered that a steroid hormone blunts the effects of marijuana, virtually eliminating its high. The hormone, pregnenolone, occurs naturally in the body. In the laboratory, it worked by ...
Tags: steroid hormone, marijuana, pregnenolone, reducing the reaction to THC
A vaccine normally used to thwart the respiratory illness tuberculosis also might help prevent the development of multiple sclerosis, a disease of the central nervous system, a new study suggests. In people who had a first episode of ...
A new analysis has found that both real and sham acupuncture treatments may help alleviate side effects of drugs commonly used to treat breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, ...
Tags: acupuncture treatments, breast cancer, alleviate side effects
United States Army researchers have found that a bio-nanomaterial can help solve a public health issue involving people showing up in emergency rooms with dangerous reactions to marijuana substitutes sold at gas stations and head shops, ...
The French maker of a drug used to treat multiple sclerosis is "extremely disappointed" it was rejected for U.S. sale, a corporate official said. David Meeker, president of Sanofi's Genzyme subsidiary, maker of the drug Lemtrada, said he ...